Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer

被引:112
作者
Zou, Peng [1 ,2 ]
Xia, Yiqun [3 ]
Ji, Jiansong [4 ]
Chen, Weiqian [1 ,4 ]
Zhang, Jinsan [1 ]
Chen, Xi [1 ]
Rajamanickam, Vinothkumar [1 ]
Chen, Gaozhi [1 ]
Wang, Zhe [1 ]
Chen, Lingfeng [1 ]
Wang, Yifeng [1 ]
Yang, Shulin [2 ]
Liang, Guang [1 ]
机构
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China
[2] Nanjing Univ Sci & Technol, Sch Environm & Biol Engn, Nanjing 210094, Jiangsu, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 1, Dept Digest Dis, Wenzhou 325035, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Intervent Radiol, Lishui 323000, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Thioredoxin reductase 1; Reactive oxygen species; Piperlongumine; ER stress; Mitochondrial dysfunction; THIOREDOXIN REDUCTASE 1; REACTIVE OXYGEN; CELL-DEATH; APOPTOSIS; STRESS; ACTIVATION; RESISTANCE; TRASTUZUMAB; GLUTATHIONE; MECHANISMS;
D O I
10.1016/j.canlet.2016.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Piperlongumine (PL), a natural alkaloid isolated from the fruit of long pepper, is known to selectively kill tumor cells while sparing their normal counterparts. However, the cellular target and potent anticancer efficacy of PL in numerous types of human cancer cells have not been fully defined. We report here that PL may interact with the thioredoxin reductase 1 (TrxR1), an important selenocysteine (Sec) containing antioxidant enzyme, to induce reactive oxygen species (ROS)-mediated apoptosis in human gastric cancer cells. By inhibiting TrxR1 activity and increasing intracellular ROS levels, PL induces a lethal endoplasmic reticulum stress and mitochondrial dysfunction in human gastric cancer cells. Importantly, knockdown of TrxR1 sensitizes cells to PL treatment, and PL displays synergistic lethality with GSH inhibitors (BSO and Erastin) against gastric cancer cells. In vivo, PL treatment markedly reduces the TrxR1 activity and tumor cell burden. Remarkably, TrxR1 was significantly overexpressed in gastric cancer cell lines and human gastric cancer tissues. Targeting TrxR1 with PL thus discloses a previously unrecognized mechanism underlying the biological activity of PL and provides an in-depth insight into the action of PL in the treatment of gastric cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:114 / 126
页数:13
相关论文
共 42 条
  • [1] Novel action of paclitaxel against cancer cells: Bystander effect mediated by reactive oxygen species
    Alexandre, Jerome
    Hu, Yumin
    Lu, Weiqin
    Pelicano, Helene
    Huang, Peng
    [J]. CANCER RESEARCH, 2007, 67 (08) : 3512 - 3517
  • [2] Overview of the therapeutic potential of piplartine (piperlongumine)
    Bezerra, Daniel P.
    Pessoa, Claudia
    de Moraes, Manoel O.
    Saker-Neto, Nicolau
    Silveira, Edilberto R.
    Costa-Lotufo, Leticia V.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (03) : 453 - 463
  • [3] Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
    Bragado, Paloma
    Armesilla, Alejandro
    Silva, Augusto
    Porras, Almudena
    [J]. APOPTOSIS, 2007, 12 (09) : 1733 - 1742
  • [4] Small molecule inhibitors of mammalian thioredoxin reductase
    Cai, Wenqing
    Zhang, Liangwei
    Song, Yanlin
    Wang, Baolin
    Zhang, Baoxin
    Cui, Xuemei
    Hu, Guanming
    Liu, Yaping
    Wu, Jincai
    Fang, Jianguo
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (02) : 257 - 265
  • [5] Regulation of cancer cell metabolism
    Cairns, Rob A.
    Harris, Isaac S.
    Mak, Tak W.
    [J]. NATURE REVIEWS CANCER, 2011, 11 (02) : 85 - 95
  • [6] Piperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP
    Chen, Yong
    Liu, Ju Mei
    Xiong, Xin Xin
    Qiu, Xin Yao
    Pan, Feng
    Liu, Di
    Lan, Shu Jue
    Jin, Si
    Yu, Shang Bin
    Chen, Xiao Qian
    [J]. ONCOTARGET, 2015, 6 (08) : 6406 - 6421
  • [7] Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
    Cheng, Ann-Lii
    Kang, Yoon-Koo
    Chen, Zhendong
    Tsao, Chao-Jung
    Qin, Shukui
    Kim, Jun Suk
    Luo, Rongcheng
    Feng, Jifeng
    Ye, Shenglong
    Yang, Tsai-Sheng
    Xu, Jianming
    Sun, Yan
    Liang, Houjie
    Liu, Jiwei
    Wang, Jiejun
    Tak, Won Young
    Pan, Hongming
    Burock, Karin
    Zou, Jessie
    Voliotis, Dimitris
    Guan, Zhongzhen
    [J]. LANCET ONCOLOGY, 2009, 10 (01) : 25 - 34
  • [8] Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
    De Nicola, Gina M.
    Karreth, Florian A.
    Humpton, Timothy J.
    Gopinathan, Aarthi
    Wei, Cong
    Frese, Kristopher
    Mangal, Dipti
    Yu, Kenneth H.
    Yeo, Charles J.
    Calhoun, Eric S.
    Scrimieri, Francesca
    Winter, Jordan M.
    Hruban, Ralph H.
    Iacobuzio-Donahue, Christine
    Kern, Scott E.
    Blair, Ian A.
    Tuveson, David A.
    [J]. NATURE, 2011, 475 (7354) : 106 - U128
  • [9] Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose
    Du, Yatao
    Zhang, Huihui
    Lu, Jun
    Holmgren, Arne
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (45) : 38210 - 38219
  • [10] Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells
    Duan, Dongzhu
    Zhang, Baoxin
    Yao, Juan
    Liu, Yaping
    Fang, Jianguo
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2014, 70 : 182 - 193